Triple
T22690292
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | CDK4 |
E561032
|
entity |
| Predicate | substrate |
P16678
|
FINISHED |
| Object | RBL2 |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: RBL2 | Statement: [CDK4, substrate, RBL2]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: RBL2 Context triple: [CDK4, substrate, RBL2]
-
A.
RBL1
RBL1 is a tumor suppressor protein of the retinoblastoma family that regulates cell cycle progression by controlling E2F transcription factor activity.
-
B.
c-Myc
c-Myc is a proto-oncogene transcription factor that regulates cell growth, proliferation, and metabolism and is frequently dysregulated in cancer.
-
C.
RB1
RB1 is a tumor suppressor protein that regulates the cell cycle by controlling the transition from G1 to S phase and is frequently inactivated in human cancers.
-
D.
Clb3
Clb3 is a B-type cyclin in budding yeast that partners with the Cdc28 kinase to regulate progression through the cell cycle, particularly during S and G2 phases.
-
E.
CDK6
CDK6 is a cyclin-dependent kinase that regulates cell cycle progression and is a key target in certain cancer therapies.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: RBL2 Target entity description: RBL2 is a tumor suppressor protein of the retinoblastoma family that regulates cell cycle progression by controlling E2F transcription factor activity.
-
A.
RBL1
RBL1 is a tumor suppressor protein of the retinoblastoma family that regulates cell cycle progression by controlling E2F transcription factor activity.
-
B.
c-Myc
c-Myc is a proto-oncogene transcription factor that regulates cell growth, proliferation, and metabolism and is frequently dysregulated in cancer.
-
C.
RB1
RB1 is a tumor suppressor protein that regulates the cell cycle by controlling the transition from G1 to S phase and is frequently inactivated in human cancers.
-
D.
Clb3
Clb3 is a B-type cyclin in budding yeast that partners with the Cdc28 kinase to regulate progression through the cell cycle, particularly during S and G2 phases.
-
E.
CDK6
CDK6 is a cyclin-dependent kinase that regulates cell cycle progression and is a key target in certain cancer therapies.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454d71b48190a1f80af9f82b6fcf |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1789a1fd08190bce5fa0babe695d3 |
completed | April 29, 2026, 3:18 a.m. |
Created at: April 17, 2026, 3:13 p.m.